Suchergebnisse - "Gu, Linping"

PubPharm (22)

1

A durable response to savolitinib in a patient with lung adenocarcinoma harboring two novel MET exon 14 skipping sites

enthalten in: Anti-cancer drugs | 2023

von Gu, L. | Zhao, Y. | Wen, F. | +3

2

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer

enthalten in: Frontiers in oncology | 2023

von Qi, Y. | Gu, L. | Shen, J. | +4

3

Real-world outcomes of immunotherapy-based neoadjuvant therapy in resectable non-small cell lung cancer

enthalten in: Frontiers in immunology | 2023

von Shen, J. | Gu, L. | Qi, Y. | +3

4

Landscape and Predictive Significance of the Structural Classification of EGFR Mutations in Chinese NSCLCs : A Real-World Study

enthalten in: Journal of clinical medicine | 2022

von Gu, L. | Huang, H. | Xu, Z. | +5

5

Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions : A case report

enthalten in: Medicine | 2022

von Gu, L. | Ji, W. | Xu, Y. | +2

6

SMO mutation affects tumor immuno-microenvironment and predicts the effect of immune checkpoint inhibitor: from NSCLC to multiple-cancers

enthalten in: ResearchSquare.com | 2022

von Ji, W. | Niu, X. | Yu, Y. | +3

7

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

enthalten in: Journal of hematology & oncology | 2022

von Zhou, Z. | Ding, Z. | Yuan, J. | +29

8

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

enthalten in: Journal of hematology & oncology | 2022

von Zhou, Z. | Ding, Z. | Yuan, J. | +29

9

Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients

enthalten in: bioRxiv.org | 2022

von Zhou, Z. | Ding, Z. | Yuan, J. | +27

10

Integrative Genomic Analysis of Drug Resistance in MET Exon 14 Skipping Lung Cancer Using Patient-Derived Xenograft Models

enthalten in: ResearchSquare.com | 2022

von Xu, Y. | Gu, L. | Li, Y. | +7